Depression Symptoms Soar During Pandemic, Study Finds
September 28, 2020
 |
The coronavirus disease 2019 (COVID-19) pandemic has been a traumatic event that is compounded by the policies enacted to prevent its spread, which have introduced new life stressors and disrupted daily living for most people in the United States (US). Early evidence suggests that... |
|
 Continue reading (Members only)
|
|
|
|
|
|
|
|
|
|
New Schizophrenia Treatment Guidelines Released by APA
September 14, 2020
 |
The American Psychiatric Association (APA) has just released its latest guidelines for the treatment of patients with schizophrenia. These new guidelines are the first APA schizophrenia guidelines to be published in over a decade. During that 10+ year interim, there have been many advancements in... |
|
Continue reading (Members only)
|
|
|
|
Olanzapine/Samidorphan Combo Found to Reduce Antipsychotic-Induced Weight Gain
September 1, 2020
 |
The combination of olanzapine, a dopamine D2 receptor antagonist, and samidorphan, an opioid receptor antagonist, is being developed for the treatment of schizophrenia and bipolar I disorder. Despite its efficacy, olanzapine is associated with significant weight gain and adverse metabolic effects that limit its clinical utility as a monotherapy. The combination of olanzapine and samidorphan has been shown to... |
|
Continue reading (Members only)
|
|
|
|
Systolic Orthostatic Hypotension Tied to Dementia Risk
August 21, 2020
 |
A recent study examined whether orthostatic hypotension and visit-to-visit blood pressure postural changes variability are associated with incident dementia.
The study involved 2,131 people aged 73 years old on average. Repeatedly over a period of five years, researchers A recent study examined whether orthostatic hypotension and visit-to-visit blood pressure postural changes variability are associated with incident dementia. The study involved 2,131 people aged 73 years old on average. Over a period of five years, researchers... |
|
Continue reading (Members only)
|
|